HLB liver cancer drug hits FDA setback again over manufacturing issues
--------------------------------------------------------------------
Source: The Korea Herald
Published: 2026-07-10 15:54 UTC+10:00
Section: All News
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, South Korea, Economy & Finance, Financial Markets, Drugs, World News, Business & Economy
--------------------------------------------------------------------
Snippet:
Korean biotechnology firm’s stock plunges by 30 percent in wake of report
--------------------------------------------------------------------